Goodman John B 4
4 · Proto Labs Inc · Filed Sep 18, 2018
Insider Transaction Report
Form 4
Proto Labs IncPRLB
Goodman John B
Director
Transactions
- Exercise/Conversion
Common Stock
2018-09-14$70.00/sh+536$37,520→ 13,191 total - Exercise/Conversion
Stock Option (right to buy)
2018-09-14−536→ 0 totalExercise: $70.00Exp: 2025-05-19→ Common Stock (536 underlying) - Exercise/Conversion
Common Stock
2018-09-14$62.68/sh+577$36,166→ 12,655 total - Sale
Common Stock
2018-09-14$162.95/sh−1,113$181,365→ 12,078 total - Exercise/Conversion
Stock Option (right to buy)
2018-09-14−577→ 0 totalExercise: $62.68Exp: 2024-05-19→ Common Stock (577 underlying)
Footnotes (4)
- [F1]Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018.
- [F2]Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018.
- [F3]Reflects the weighted average price of 1,113 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 14, 2018 with sale prices ranging from $162.95 to $163.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]Fully vested.